Halozyme Therapeutics shares owned by ExodusPoint Capital Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by ExodusPoint Capital Management
from 13F filings
Historical chart of ExodusPoint Capital Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by ExodusPoint Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by ExodusPoint Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $4.5M | 86k | 52.02 |
| 2023-09-30 | $2.0M | 53k | 38.21 |
| 2023-06-30 | $12M | 340k | 36.07 |
| 2023-03-31 | $5.9M | 154k | 38.19 |
| 2022-12-31 | $5.5M | 97k | 56.90 |
| 2022-09-30 | $3.9M | 99k | 39.54 |
| 2022-06-30 | $7.1M | 160k | 44.00 |
| 2022-03-31 | $5.1M | 128k | 39.88 |
| 2021-12-31 | $2.2M | 55k | 40.21 |
| 2021-03-31 | $1.3M | 32k | 41.70 |
| 2020-09-30 | $1.4M | 52k | 26.27 |
| 2020-06-30 | $1.3M | 49k | 26.81 |
| 2019-12-31 | $479k | 27k | 17.72 |
More positions owned by ExodusPoint Capital Management
View all positions for ExodusPoint Capital Management